Search

Displaying results 9581 - 9590 of 10000 in total
  1. Drug

    Otilonium

    go.drugbank.com/drugs/DB13500
    Investigational

    Categories: Drugs for Functional Gastrointestinal DisordersProducts: BROPASMOL(R)40 MG TABLETAS
  2. Drug

    Cedar oil

    go.drugbank.com/drugs/DB10917
    Approved

    Cedar oil (Juniperus virginiana) allergenic extract is used in allergenic testing.

  3. Drug

    5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole

    go.drugbank.com/drugs/DB08722
    Experimental

    5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. … These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole targets the protein genome polyprotein

  4. Drug

    Putrescine

    go.drugbank.com/drugs/DB01917
    Investigational

    Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. Putrescine is a solid. This compound belongs to the polyamines.

  5. Drug

    NF-kappaB Decoy

    go.drugbank.com/drugs/DB05559
    Investigational

    Synonyms: NF-KB Decoy, NF-kappaB Decoy
  6. Drug

    Facinicline

    go.drugbank.com/drugs/DB05586
    Investigational

  7. Drug

    Talotrexin

    go.drugbank.com/drugs/DB06178
    Investigational

  8. Drug

    Cibenzoline

    go.drugbank.com/drugs/DB13358
    Investigational

    Categories: Antiarrhythmics, Class I, Antiarrhythmics, Class Ia
  9. Drug

    Gam-COVID-Vac

    go.drugbank.com/drugs/DB15848
    Investigational

    Preliminary results suggested that all participants developed antibodies to the SARS-CoV-2 glycoproteins with a good safety profile in both trials. … June 2020, and were completed in early August 2020.

  10. Drug

    BBV152

    go.drugbank.com/drugs/DB15847
    Investigational

    Thus, as of July 2020, BBV152 is in Phase 1/2 clinical trials assessing safety and immunogenicity in humans (NCT04471519). … Animal studies in mice, rats, and rabbits reported BBV152 immunogenicity at two separate antigen concentrations with both types of adjuvants.